Keywords: astrazeneca, third-quarter, profits, grow, losec/prilosec, sales, soar

AstraZeneca third-quarter profits grow 56% as Losec/Prilosec sales soar

Article | 28 October 1999

Print This

AstraZeneca has posted a strong set of results for the third quarter of1999, with group turnover rising 22% (at constant currency ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in